Orthopedic Surgery Doctors in Vancleave, MS Accepting Medicare

7 Orthopedic Surgery doctors found. Showing 1 - 7

Matthew Wesley Lewis, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6300 E Lake Blvd, Suite 201, Vancleave, MS 39565 Phone: 228-206-2263    Fax: 228-206-1192

Charles Joseph Winters, M.D. Orthopaedic Surgery - Orthopaedic Surgery of the Spine Medicare: Accepting Medicare Assignments Practice Location: 6300 E Lake Blvd Ste 201, Vancleave, MS 39565 Phone: 228-230-2663    Fax: 228-546-3257

Dr. Daniel Allen Wittersheim, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6300 E Lake Blvd, Suite 201, Vancleave, MS 39565 Phone: 228-230-2663    Fax: 228-206-1192

Dr. John Kirk Drake, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6300 E Lake Blvd, Suite 201, Vancleave, MS 39565 Phone: 228-230-2663    Fax: 228-206-1192

Thomas Jordan Lucak, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6300 E Lake Blvd Ste 201, Vancleave, MS 39565 Phone: 228-230-2663    Fax: 228-546-3257

David P Taormina, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6300 E Lake Blvd Ste 201, Vancleave, MS 39565 Phone: 228-230-2663    Fax: 228-546-3257

Dr. Christopher Burks, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6300 E Lake Blvd, Suite 301, Vancleave, MS 39565 Phone: 228-230-2663    Fax: 228-206-1192

News Archive

Danish scientists have identified which head and neck cancer patients will benefit from additional drug treatment during radiotherapy

Tumours that have low concentrations of oxygen (hypoxia) are resistant to radiotherapy. A drug called nimorazole (a hypoxia radiosensitiser) can improve the outcome of radiotherapy for patients with these types of tumours. However, at the moment there is no way to identify people with tumours that lack oxygen, who need this additional drug treatment, from those that only need radiotherapy.

NPC, Sanford Wittels & Heisler announce amicable end to litigation

Novartis Pharmaceuticals Corporation, a US subsidiary of Novartis AG, and Sanford Wittels & Heisler, LLP, Counsel to the Plaintiffs and the Class, have announced an amicable end to their litigation. Today the parties filed papers in the Southern District of New York memorializing a settlement agreement including up to USD 152.5 million in payments to eligible class members and NPC's funding, over three years, of improvements to policies and programs valued at an estimated USD 22.5 million.

Drug discovery research at University of Nottingham supported by SPT Labtech

SPT Labtech, global developer and manufacturer of high quality, robust and innovative automated laboratory equipment, is enabling a successful new venture at the University of Nottingham's Centre for Biomolecular Science, with its comPOUND® sample storage system and comPILER® high throughput, tube-to-plate processing system.

‘Off the shelf' new livers from stem cells, glimmer of hope

A researcher team has successfully produced a small-scale version of a human liver in the laboratory using stem cells. This could be a boon for patients waiting for liver transplants although it will take years to perfect the procedure say researchers.

AbleNet to showcase assistive technology products at Heartland Home for Independent Living

AbleNet, Inc. is showcasing its newest and most popular access, environmental controls and communications products at the Heartland Home for Independent Living. The model home is being constructed as an all-accessible home to give conference attendees first-hand experience with the many innovative design features and the leading accessibility products that enhance independent and functional living for people with disabilities.

Read more Medical News

› Verified 2 days ago